Medibank PvtASX:MPL 77 Debt-to-EBITDA is 0.28 as of Dec. 2025, which is 8% above its 10-year median of 0.26. GuruFocus rates ASX:MPL with a GF Score™ of 77/100 and a GF Value™ of A$4.40 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 322 Insurance companies, Medibank Pvt ranks better than 77.33% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Medibank Pvt's Debt-to-EBITDA or its related term are showing as below:
ASX:MPL'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.25 Med: 0.26 Max: 0.35
Current: 0.35
During the past 11 years, the highest Debt-to-EBITDA Ratio of Medibank Pvt was 0.35. The lowest was 0.25. And the median was 0.26.
ASX:MPL's Debt-to-EBITDA is ranked better than 77.33% of 322
companies
in the Insurance industry
Industry Median: 1.175
vs ASX:MPL: 0.35
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Medibank Pvt Debt-to-EBITDA Related Terms
Medibank Pvt Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Medibank Pvt's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:MPL vs FNF, AXS, FAF: Debt-to-EBITDA Comparison
For the Insurance - Specialty subindustry, Medibank Pvt's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medibank Pvt Debt-to-EBITDA vs Insurance Industry
For the Insurance industry and Financial Services sector, Medibank Pvt's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medibank Pvt's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
Medibank Pvt (ASX:MPL) has a Debt-to-EBITDA of 0.28 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Medibank Pvt. This is near median its historical median of 0.26. Over the past decade, Medibank Pvt's Debt-to-EBITDA has ranged from 0.25 to 0.35. According to the industry distribution chart, Medibank Pvt ranks #73 out of 322 companies in the Insurance industry, placing it in the top 22.7%.
Is Medibank Pvt's Debt-to-EBITDA too high?
Medibank Pvt's current Debt-to-EBITDA of 0.28 is near median its 10-year median of 0.26. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 0.35. The Insurance industry median Debt-to-EBITDA is 1.18. Medibank Pvt's value of 0.28 is 76.2% below this industry median. Based on the distribution chart, Medibank Pvt ranks #73 out of 322 companies in the Insurance industry, which is in the top quartile — a strong position relative to peers. Overall, Medibank Pvt has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's Debt-to-EBITDA compare to FNF and AXS?
According to the Insurance industry distribution chart, Medibank Pvt ranks #73 out of 322 companies for Debt-to-EBITDA. This places Medibank Pvt in the top 23% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 1.18. Medibank Pvt's value of 0.28 is 76.2% below this benchmark. Historically, Medibank Pvt's own Debt-to-EBITDA has ranged from 0.25 to 0.35 over the past decade. While the company's 10-year median is 0.26 vs. the industry median of 1.18, Medibank Pvt has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for an Insurance company?
The median Debt-to-EBITDA among Insurance companies is 1.18, based on 322 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medibank Pvt's current Debt-to-EBITDA of 0.28 is 76.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Medibank Pvt. For the Insurance industry, the median Debt-to-EBITDA is 1.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medibank Pvt's current Debt-to-EBITDA is 0.28, which is near median its own 10-year median of 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.40, compared to a current price of A$5.04 — trading 14.5% above its estimated fair value. The current Debt-to-EBITDA is 0.28, which is near median its 10-year median of 0.26 and 76.2% below the Insurance industry median of 1.18. Medibank Pvt's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current Debt-to-EBITDA is 0.28 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medibank Pvt (ASX:MPL) Overvalued in 2026?
Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued.
The current stock price of A$5.04 is trading 14.5% above its estimated GF Value™ of A$4.40.
GuruFocus considers Medibank Pvt to be Modestly Overvalued.
Key valuation signals for ASX:MPL:
Debt-to-EBITDA: 0.28 (near median its 10-year median of 0.26)
GF Value™: A$4.40 vs. price of A$5.04 (14.5% above fair value)
Industry Position: 76.2% below the Insurance median (#73 of 322)
No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
77GF Score
Get the complete analysis for ASX:MPL
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MPL has been successfully added to your 
